| dc.contributor.author | Lee, Sarah Yunmi | |
| dc.contributor.author | Fujiwara, Yuji | |
| dc.contributor.author | Nishiguchi, Atsuko | |
| dc.contributor.author | Kalek, Marcin | |
| dc.contributor.author | Fu, Gregory C. | |
| dc.date.accessioned | 2015-06-22T14:48:49Z | |
| dc.date.available | 2015-06-22T14:48:49Z | |
| dc.date.issued | 2015-03 | |
| dc.date.submitted | 2015-02 | |
| dc.identifier.issn | 0002-7863 | |
| dc.identifier.issn | 1520-5126 | |
| dc.identifier.uri | http://hdl.handle.net/1721.1/97494 | |
| dc.description.abstract | Substantial progress has been described in the development of asymmetric variants of the phosphine-catalyzed intermolecular [3+2] annulation of allenes with alkenes; however, there have not been corresponding advances for the intramolecular process, which can generate a higher level of complexity (an additional ring and stereocenter(s)). In this study, we describe the application of chiral phosphepine catalysts to address this challenge, thereby providing access to useful scaffolds that are found in bioactive compounds, including diquinane and quinolin-2-one derivatives, with very good stereoselectivity. The products of the [3+2] annulation can be readily transformed into structures that are even more stereochemically rich. Mechanistic studies are consistent with β addition of the phosphepine to the allene being the turnover-limiting step of the catalytic cycle, followed by a concerted [3+2] cycloaddition to the pendant olefin. | en_US |
| dc.description.sponsorship | National Institute of General Medical Sciences (U.S.) (R01-GM57034) | en_US |
| dc.description.sponsorship | Dainippon Pharmaceutical Co., Ltd. (Fellowship) | en_US |
| dc.description.sponsorship | Takeda Pharmaceutical Co., Ltd. (Fellowship) | en_US |
| dc.language.iso | en_US | |
| dc.publisher | American Chemical Society (ACS) | en_US |
| dc.relation.isversionof | http://dx.doi.org/10.1021/jacs.5b01985 | en_US |
| dc.rights | Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. | en_US |
| dc.source | American Chemical Society | en_US |
| dc.title | Phosphine-Catalyzed Enantioselective Intramolecular [3+2] Annulations To Generate Fused Ring Systems | en_US |
| dc.type | Article | en_US |
| dc.identifier.citation | Lee, Sarah Yunmi, Yuji Fujiwara, Atsuko Nishiguchi, Marcin Kalek, and Gregory C. Fu. “Phosphine-Catalyzed Enantioselective Intramolecular [3+2] Annulations To Generate Fused Ring Systems.” Journal of the American Chemical Society 137, no. 13 (April 8, 2015): 4587–4591. © 2015 American Chemical Society | en_US |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Chemistry | en_US |
| dc.contributor.mitauthor | Lee, Sarah Yunmi | en_US |
| dc.contributor.mitauthor | Fujiwara, Yuji | en_US |
| dc.contributor.mitauthor | Nishiguchi, Atsuko | en_US |
| dc.contributor.mitauthor | Fu, Gregory C. | en_US |
| dc.relation.journal | Journal of the American Chemical Society | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dspace.orderedauthors | Lee, Sarah Yunmi; Fujiwara, Yuji; Nishiguchi, Atsuko; Kalek, Marcin; Fu, Gregory C. | en_US |
| mit.license | PUBLISHER_POLICY | en_US |
| mit.metadata.status | Complete | |